Sonia M. Vallabh
Sonia M. Vallabh | |
|---|---|
.jpg) Vallabh in 2025 | |
| Born | March 19, 1984 |
| Occupation | Researcher |
| Spouse | Eric Vallabh Minikel |
| Children | 2 |
| Academic background | |
| Alma mater | Harvard University |
| Thesis | Antisense Oligonucleotides for the Prevention of Genetic Prion Disease (2019) |
| Stuart L. Schreiber | |
| Academic work | |
| Discipline | Biological and Biomedical Sciences |
Sonia Minikel Vallabh is an American scientist focused on prion diseases, particularly fatal familial insomnia. She is noted for being a "patient-scientist" who proactively studies a genetic disorder she is a patient of, aiming to cure it before it kills her.[1][2][3]
Biography
Before beginning her career as a scientist, Vallabh studied and practiced law, having graduated from Harvard Law School and Swarthmore College.[4] In 2010, her mother, Kamni, suddenly developed profound and aggressive dementia that killed her six months after symptoms first developed. An autopsy revealed that her mother had died from fatal familial insomnia, an incurable genetic disorder that causes misfolded proteins to destroy the brain. A blood sample from Vallabh herself revealed she had inherited the causal mutation.[5]
The revelation inspired Vallabh and her husband, Eric Vallabh Minikel, to retrain as biomedical scientists with the goal of saving her life.[6][7] She received a Doctorate of Philosophy from Harvard in 2019 and became a senior leader at the Broad Institute prion lab.[8]
In October 2012, Vallabh and her husband founded the Prion Alliance, a non-profit 501(c)(3) organization dedicated towards scientific research into prion disease treatment and cure.[9]
In 2023, she earned the Paper of the Year Award from the Oligonucleotide Therapeutics Society.[10]
As of 2026, prion diseases remain invariably fatal. However, research published by Vallabh and her husband may represent the first steps towards treatment. In 2024, the group described CHARM, an engineered protein that selectively silences the expression of PrnP, the gene responsible for inherited prion diseases.[11] In 2025, they found that CHARM prolonged the lives of rats with prion disease by 52%.[12][13][14]
Vallabh has two children, both born via IVF and genetic screening in order to avoid the possibility of them inheriting her disorder. She noted that she felt "lucky" to live in Massachusetts which provided relative affordability for IVF treatment.[15]
References
- ↑ Clancy, Kelly. "One Couple's Tireless Crusade to Stop a Genetic Killer". Wired. ISSN 1059-1028. Retrieved 2025-11-08.
- ↑ Swartz, Aimee (2015-02-05). "Insomnia That Kills". The Atlantic. Retrieved 2025-11-08.
- ↑ Burge, Kathleen (2016-02-17). "A husband and wife's race to cure her fatal genetic disease". Boston Globe. Retrieved 2025-11-08.
- ↑ "Sonia Vallabh". Broad Institute. 2015-08-20. Retrieved 2025-11-08.
- ↑ Bichell, Rae Ellen (2017-06-19). "A Couple's Quest To Stop A Rare Disease Before It Takes One Of Them". NPR. Retrieved 2025-11-08.
- ↑ Vallabh, Sonia; LeMieux, Julianna (October 2024). "Preventing Prion Disease: An Interview with Sonia Vallabh". GEN Biotechnology. 3 (5): 278–281. doi:10.1089/genbio.2024.0052. ISSN 2768-1572.
- ↑ Vallabh, Sonia M. (2020-01-09). "The Patient-Scientist's Mandate". New England Journal of Medicine. 382 (2): 107–109. doi:10.1056/nejmp1909471. ISSN 0028-4793. PMID 31914240.
- ↑ Friar, Greta (2024-06-26). "A CHARMed collaboration created a potent therapy candidate for fatal prion diseases". Whitehead Institute of MIT. Retrieved 2025-11-08.
- ↑ "Prion Alliance". www.prionalliance.org. Retrieved 2026-04-02.
- ↑ OTS (2023-12-22). "2023 Paper of the Year Award - Basic Research Category Winner Sonia Vallabh". Oligonucleotide Therapeutics Society. Retrieved 2025-11-08.
- ↑ Neumann, Edwin N.; Bertozzi, Tessa M.; Wu, Elaine; Serack, Fiona; Harvey, John W.; Brauer, Pamela P.; Pirtle, Catherine P.; Coffey, Alissa; Howard, Michael; Kamath, Nikita; Lenz, Kenney; Guzman, Kenia; Raymond, Michael H.; Khalil, Ahmad S.; Deverman, Benjamin E. (2024-06-28). "Brainwide silencing of prion protein by AAV-mediated delivery of an engineered compact epigenetic editor". Science. 384 (6703) ado7082. Bibcode:2024Sci...384o7082N. doi:10.1126/science.ado7082. ISSN 0036-8075. PMC 11875203. PMID 38935715.
- ↑ "Epigenetic editors are a gentler form of gene editing". The Economist. 2025-02-24. ISSN 0013-0613. Retrieved 2025-11-08.
- ↑ Powell, Alvin (2025-04-07). "Team hits milestone toward prion disease treatment". Harvard Gazette. Retrieved 2025-11-08.
- ↑ An, Meirui; Davis, Jessie R.; Levy, Jonathan M.; Serack, Fiona E.; Harvey, John W.; Brauer, Pamela P.; Pirtle, Catherine P.; Berríos, Kiara N.; Newby, Gregory A.; Yeh, Wei-Hsi; Kamath, Nikita; Mortberg, Meredith; Lian, Yuan; Howard, Michael; DeSouza-Lenz, Kendrick (April 2025). "In vivo base editing extends lifespan of a humanized mouse model of prion disease". Nature Medicine. 31 (4): 1319–1328. doi:10.1038/s41591-024-03466-w. ISSN 1546-170X. PMC 12003183. PMID 39810005.
- ↑ Eden, Lillian (2024-07-01). "She's fighting to stop the brain disease that killed her mother before it gets her". MIT Department of Biology. Retrieved 2026-08-16.
External links
